Revenue: The sum of all revenue fields included for a company's operating activities.
Arbutus Biopharma Corporation (ABUS) had Revenue of $10.74M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$10.74M |
$2.52M |
|
-- |
|
$10.74M |
|
$9.25M |
|
$1.49M |
|
$1.03M |
|
$2.52M |
|
$2.52M |
|
$2.52M |
|
$2.52M |
|
$2.52M |
|
$2.52M |
|
$1.49M |
|
$1.50M |
|
191.55M |
|
192.40M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$103.12M |
|
$0.15M |
|
$0.15M |
|
$103.27M |
|
$5.02M |
|
-- |
|
$15.27M |
|
$20.29M |
|
$82.98M |
|
$82.98M |
|
$82.98M |
|
191.64M |
|
| Cash Flow Statement Financials | |
$-29.14M |
|
$26.96M |
|
$3.24M |
|
$36.33M |
|
$37.41M |
|
$1.08M |
|
$4.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
13.86% |
|
13.86% |
|
-- |
|
23.49% |
|
23.49% |
|
$-29.13M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
10.48 |
|
8.59 |
|
3.04% |
|
3.04% |
|
2.44% |
|
3.04% |
|
$0.43 |
|
$-0.15 |
|
$-0.15 |
|